Friday, October 28, 2016

Dicynene




Dicynene may be available in the countries listed below.


UK matches:

  • Dicynene
  • Dicynene 500 Tablets (SPC)

Ingredient matches for Dicynene



Etamsylate

Etamsylate is reported as an ingredient of Dicynene in the following countries:


  • Ireland

  • United Kingdom

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Suprimal




Suprimal may be available in the countries listed below.


Ingredient matches for Suprimal



Meclozine

Meclozine dihydrochloride (a derivative of Meclozine) is reported as an ingredient of Suprimal in the following countries:


  • Netherlands

Mesalazine

Mesalazine is reported as an ingredient of Suprimal in the following countries:


  • Argentina

International Drug Name Search


Serotonin-norepinephrine reuptake inhibitors


A drug may be classified by the chemical type of the active ingredient or by the way it is used to treat a particular condition. Each drug can be classified into one or more drug classes.

Serotonin-norepinephrine reuptake inhibitors (SNRIs) block or delay the reuptake of the neurotransmitters, serotonin and norepinephrine, by the presynaptic nerves. This increases the levels of these two neurotransmitters in the synapse and tends to elevate mood.


Serotonin-norepinephrine reuptake inhibitors (SNRIs) are used to treat depression, anxiety disorder, panic disorder and other mood disorders.

See also

Medical conditions associated with serotonin-norepinephrine reuptake inhibitors:

  • ADHD
  • Anxiety
  • Anxiety and Stress
  • Autism
  • Back Pain
  • Bipolar Disorder
  • Bulimia
  • Cataplexy
  • Chronic Fatigue Syndrome
  • Depression
  • Diabetic Nerve Damage
  • Dysthymia
  • Fibromyalgia
  • Generalized Anxiety Disorder
  • Hot Flashes
  • Irritable Bowel Syndrome
  • Narcolepsy
  • Neuralgia
  • Obesity
  • Obsessive Compulsive Disorder
  • Osteoarthritis
  • Pain
  • Panic Disorder
  • Peripheral Neuropathy
  • Post Traumatic Stress Disorder
  • Postmenopausal Symptoms
  • Postpartum Depression
  • Premenstrual Dysphoric Disorder
  • Reflex Sympathetic Dystrophy Syndrome
  • Social Anxiety Disorder
  • Urinary Incontinence
  • Vulvodynia

Drug List:


Sonazine




Ingredient matches for Sonazine



Chlorpromazine

Chlorpromazine hydrochloride (a derivative of Chlorpromazine) is reported as an ingredient of Sonazine in the following countries:


  • United States

International Drug Name Search


Nutramid




Nutramid may be available in the countries listed below.


Ingredient matches for Nutramid



Metoclopramide

Metoclopramide hydrochloride (a derivative of Metoclopramide) is reported as an ingredient of Nutramid in the following countries:


  • Bangladesh

International Drug Name Search


Thursday, October 27, 2016

Hydro-Cebral-ratiopharm




Hydro-Cebral-ratiopharm may be available in the countries listed below.


Ingredient matches for Hydro-Cebral-ratiopharm



Dihydroergotoxine

Dihydroergotoxine mesilate (a derivative of Dihydroergotoxine) is reported as an ingredient of Hydro-Cebral-ratiopharm in the following countries:


  • Germany

International Drug Name Search


Dihalar




Dihalar may be available in the countries listed below.


Ingredient matches for Dihalar



Ketotifen

Ketotifen is reported as an ingredient of Dihalar in the following countries:


  • Slovenia

Ketotifen fumarate (a derivative of Ketotifen) is reported as an ingredient of Dihalar in the following countries:


  • Croatia (Hrvatska)

International Drug Name Search


Spartrix




In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Spartrix



Carnidazole

Carnidazole is reported as an ingredient of Spartrix in the following countries:


  • Belgium

  • France

  • Germany

  • Netherlands

  • United Kingdom

  • United States

International Drug Name Search


Oxaliplatin Kabi




Oxaliplatin Kabi may be available in the countries listed below.


Ingredient matches for Oxaliplatin Kabi



Oxaliplatin

Oxaliplatin is reported as an ingredient of Oxaliplatin Kabi in the following countries:


  • Germany

International Drug Name Search


Neo Balgin HD




Neo Balgin HD may be available in the countries listed below.


Ingredient matches for Neo Balgin HD



Barium Sulfate

Barium Sulfate is reported as an ingredient of Neo Balgin HD in the following countries:


  • Japan

International Drug Name Search


Glycopeptide antibiotics


A drug may be classified by the chemical type of the active ingredient or by the way it is used to treat a particular condition. Each drug can be classified into one or more drug classes.

Glycopeptide antibiotics inhibit bacterial cell wall formation by inhibiting peptidoglycan synthesis. They are used for treating methicillin-resistant staphylococcus aureus (MRSA) infections and enterococcal infections, which are resistant to beta-lactams and other antibiotics. They are also used in cases where there is allergy to beta-lactams.

See also

Medical conditions associated with glycopeptide antibiotics:

  • Bacteremia
  • Bacterial Endocarditis Prevention
  • Bacterial Infection
  • Bone infection
  • Burns, External
  • Clostridial Infection
  • Endocarditis
  • Enterocolitis
  • Febrile Neutropenia
  • Meningitis
  • Methicillin-Resistant Staphylococcus Aureus Infection
  • Nosocomial Pneumonia
  • Peritonitis
  • Pneumonia
  • Prevention of Perinatal Group B Streptococcal Disease
  • Pseudomembranous Colitis
  • Sepsis
  • Shunt Infection
  • Skin and Structure Infection
  • Skin Infection
  • Surgical Prophylaxis

Drug List:


Neo-Tiroimade




Neo-Tiroimade may be available in the countries listed below.


Ingredient matches for Neo-Tiroimade



Liothyronine

Liothyronine sodium salt (a derivative of Liothyronine) is reported as an ingredient of Neo-Tiroimade in the following countries:


  • Portugal

International Drug Name Search


Wednesday, October 26, 2016

Veterinair Norit




Veterinair Norit may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Veterinair Norit



Charcoal

Charcoal, Activated is reported as an ingredient of Veterinair Norit in the following countries:


  • Netherlands

International Drug Name Search


Diaphage




Diaphage may be available in the countries listed below.


Ingredient matches for Diaphage



Metformin

Metformin is reported as an ingredient of Diaphage in the following countries:


  • Bahrain

  • Iraq

  • Jordan

  • Libya

  • Qatar

  • Saudi Arabia

  • Sudan

  • United Arab Emirates

  • Yemen

Metformin hydrochloride (a derivative of Metformin) is reported as an ingredient of Diaphage in the following countries:


  • Czech Republic

  • Oman

International Drug Name Search


Urotrol




In the US, Urotrol (oxybutynin systemic) is a member of the drug class urinary antispasmodics and is used to treat Dysuria, Hyperhidrosis, Overactive Bladder, Prostatitis and Urinary Incontinence.

US matches:

  • Urotrol

Ingredient matches for Urotrol



Propiverine

Propiverine hydrochloride (a derivative of Propiverine) is reported as an ingredient of Urotrol in the following countries:


  • Taiwan

Tolterodine

Tolterodine tartrate (a derivative of Tolterodine) is reported as an ingredient of Urotrol in the following countries:


  • Spain

International Drug Name Search


Valaciclovir Helvepharm




Valaciclovir Helvepharm may be available in the countries listed below.


Ingredient matches for Valaciclovir Helvepharm



Valacyclovir

Valaciclovir hydrochloride (a derivative of Valaciclovir) is reported as an ingredient of Valaciclovir Helvepharm in the following countries:


  • Switzerland

International Drug Name Search


Sulfametoxazol+Trimetoprima Elifarma




Sulfametoxazol+Trimetoprima Elifarma may be available in the countries listed below.


Ingredient matches for Sulfametoxazol+Trimetoprima Elifarma



Sulfamethoxazole

Sulfamethoxazole is reported as an ingredient of Sulfametoxazol+Trimetoprima Elifarma in the following countries:


  • Peru

Trimethoprim

Trimethoprim is reported as an ingredient of Sulfametoxazol+Trimetoprima Elifarma in the following countries:


  • Peru

International Drug Name Search


Zivas




Zivas may be available in the countries listed below.


Ingredient matches for Zivas



Simvastatin

Simvastatin is reported as an ingredient of Zivas in the following countries:


  • Philippines

International Drug Name Search


Duo-Decadron




Duo-Decadron may be available in the countries listed below.


Ingredient matches for Duo-Decadron



Dexamethasone

Dexamethasone 21-acetate and 21-(disodium phosphate) (a derivative of Dexamethasone) is reported as an ingredient of Duo-Decadron in the following countries:


  • Argentina

  • Brazil

  • Colombia

International Drug Name Search


Neurilan




Neurilan may be available in the countries listed below.


Ingredient matches for Neurilan



Bromazepam

Bromazepam is reported as an ingredient of Neurilan in the following countries:


  • Brazil

International Drug Name Search


Oxcarbazépine




Oxcarbazépine may be available in the countries listed below.


Ingredient matches for Oxcarbazépine



Oxcarbazepine

Oxcarbazépine (DCF) is known as Oxcarbazepine in the US.

International Drug Name Search

Glossary

DCFDénomination Commune Française

Click for further information on drug naming conventions and International Nonproprietary Names.

Herbal Supplementation Medications


Drugs associated with Herbal Supplementation

The following drugs and medications are in some way related to, or used in the treatment of Herbal Supplementation. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.





Drug List:


Napsod




Napsod may be available in the countries listed below.


Ingredient matches for Napsod



Naproxen

Naproxen is reported as an ingredient of Napsod in the following countries:


  • Bangladesh

International Drug Name Search


Nebivolol AL




Nebivolol AL may be available in the countries listed below.


Ingredient matches for Nebivolol AL



Nebivolol

Nebivolol is reported as an ingredient of Nebivolol AL in the following countries:


  • Germany

International Drug Name Search


Amitiza


Amitiza is a brand name of lubiprostone, approved by the FDA in the following formulation(s):


AMITIZA (lubiprostone - capsule; oral)



  • Manufacturer: SUCAMPO PHARMS

    Approval date: January 31, 2006

    Strength(s): 24MCG [RLD]


  • Manufacturer: SUCAMPO PHARMS

    Approval date: April 29, 2008

    Strength(s): 8MCG

Has a generic version of Amitiza been approved?


No. There is currently no therapeutically equivalent version of Amitiza available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Amitiza. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Prostaglandins E and anti ulcers containing same
    Patent 5,284,858
    Issued: February 8, 1994
    Inventor(s): Ueno; Ryuzo & Ueno; Ryuji & Kato; Ichie & Oda; Tomio
    Assignee(s): Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo
    The novel 13, 14-dihydro-15-keto prostaglandins E of the invention have remarkable preventive effects against ulcers. Further, the novel 13,14-dihydro-15-ketoprostaglandins E of the invention have an advatage that they have none of side effects which prostaglandin E intrinsically has, or can remarakably reduce such effects of the prostaglandin E. Therefore, the novel 13, 14-dihydro-15-keto prostaglandins E of the invention are effective for animal and human use for treatment and prevention of ulcers, such as duodenal ulcer and gastric ulcer.
    Patent expiration dates:

    • July 14, 2014
      ✓ 
      Drug substance




  • Anti-constipation composition
    Patent 6,414,016
    Issued: July 2, 2002
    Inventor(s): Ryuji; Ueno
    Assignee(s): Sucampo, A.G.
    An object of the present invention is to provide an anti-constipation composition containing a halogenated-bi-cyclic compound as an active ingredient in a ratio of bi-cyclic/mono-cyclic structure of at least 1:1. The halogenated-bi-cyclic compound is represented by Formula (I): where X1 and X2 are preferably both fluorine atoms. The composition can be used to treat constipation without substantive side-effects, such as stomachache.
    Patent expiration dates:

    • September 5, 2020
      ✓ 
      Patent use: METHOD OF RELIEVING OR PREVENTING CONSTIPATION IN A HUMAN CONSTIPATED PATIENT


    • September 5, 2020
      ✓ 
      Patent use: METHOD OF TREATING CONSTIPATION IN A PATIENT WITH IRRITABLE BOWEL SYNDROME




  • Composition and method for stabilizing the same
    Patent 6,583,174
    Issued: June 24, 2003
    Inventor(s): Ryuji; Ueno & Tsuyoshi; Habe
    Assignee(s): Sucampo, A.G.
    Disclosed is a novel composition comprising a novel bi-cyclic compound, which is expected to be pharmaceutically active, and a glyceride. The stability of the bi-cyclic compound can be improved significantly by dissolving the same in a glyceride.
    Patent expiration dates:

    • October 16, 2020
      ✓ 
      Drug product




  • Chloride channel opener
    Patent 7,064,148
    Issued: June 20, 2006
    Inventor(s): Ueno; Ryuji & Cuppoletti; John
    Assignee(s): Sucampo AG
    Disclosed is a novel use of a prostaglandin compound as a chloride channel opener. According to the instant invention, chloride channels in a mammalian subject can be opened by a prostaglandin compound to facilitate chloride ion transportation.
    Patent expiration dates:

    • August 30, 2022
      ✓ 
      Patent use: METHOD FOR TREATING CONSTIPATION BY OPENING CIC CHANNELS IN A MAMALIAN SUBJECT


    • August 30, 2022
      ✓ 
      Patent use: METHOD OF TREATING CONSTIPATION IN A PATIENT WITH IRRITABLE BOWEL SYNDROME BY OPENING CHLORIDE CHANNELS (CIC)




  • Composition and method for stabilizing the same
    Patent 7,417,067
    Issued: August 26, 2008
    Inventor(s): Ueno; Ryuji & Habe; Tsuyoshi
    Assignee(s): Sucampo AG
    Disclosed is a novel composition comprising a novel bi-cyclic compound, which is expected to be pharmaceutically active, and a glyceride. The stability of the bi-cyclic compound can be improved significantly by dissolving the same in a glyceride.
    Patent expiration dates:

    • October 16, 2020
      ✓ 
      Drug product




  • Method for treating abdominal discomfort
    Patent 7,795,312
    Issued: September 14, 2010
    Inventor(s): Ueno; Ryuji & Kuno; Sachiko
    Assignee(s): Sucampo AG
    A method for treating irritable bowel syndrome in a mammalian subject includes administering an effective amount of 13,14-dihydro-15-keto-16,16-difluoro-18-methyl-prostaglandin E1 or 13,14-dihydro-15-keto-16,16-difluoro-prostaglandin E1, or a salt, ether, ester or amide thereof, to the subject. A method for treating abdominal discomfort associated with irritable bowel syndrome in a mammalian subject includes administering an effective amount of 13,14-dihydro-15-keto-16,16-difluoro-18-methyl-prostaglandin E1 or 13,14-dihydro-15-keto-16,16-difluoro-prostaglandin E1, or a salt, ether, ester or amide thereof, to the subject.
    Patent expiration dates:

    • September 17, 2024
      ✓ 
      Patent use: METHOD FOR TREATING IRRITABLE BOWEL SYNDROME AND METHOD FOR TREATING ABDOMINAL DISCOMFORT ASSOCIATED WITH IRRITABLE BOWEL SYNDROME




  • Soft-gelatin capsule formulation
    Patent 8,026,393
    Issued: September 27, 2011
    Inventor(s): Hashitera; Yukiko & Hirata; Ryu & Harada; Yasuhiro & Ueno; Ryuji
    Assignee(s): Sucampo AG
    R-Tech Ueno, Ltd.
    The present invention discloses a soft gelatin capsule formulation of a 15-keto-prostaglandin compound, which comprises: a soft gelatin capsule shell comprising gelatin and sugar alcohol as a plasticizer, and a mixture comprising a 15-keto-prostaglandin compound and a pharmaceutically acceptable vehicle which is filled in the shell. By encapsulating the 15-keto-prostaglandin compound in the specified soft gelatin capsule shell, stability of the compound is significantly improved.
    Patent expiration dates:

    • October 25, 2027
      ✓ 
      Drug product




  • Anti-constipation composition
    Patent 8,071,613
    Issued: December 6, 2011
    Inventor(s): Ueno; Ryuji
    Assignee(s): Sucampo AG
    An object of the present invention is to provide an anti-constipation composition containing a halogenated-bi-cyclic compound as an active ingredient in a ratio of bi-cyclic/mono-cyclic structure of at least 1:1. The halogenated-bi-cyclic compound is represented by Formula (I): where X1 and X2 are preferably both fluorine atoms. The composition can be used to treat constipation without substantive side-effects, such as stomachache.
    Patent expiration dates:

    • September 5, 2020
      ✓ 
      Patent use: METHOD FOR RELIEVING OR TREATING CONSTIPATION IN A HUMAN CONSTIPATED PATIENT


    • September 5, 2020
      ✓ 
      Patent use: METHOD FOR RELIEVING OR TREATING CONSTIPATION IN A PATIENT WITH IRRITABLE BOWEL SYNDROME




  • Composition and method for stabilizing the same
    Patent 8,088,934
    Issued: January 3, 2012
    Inventor(s): Ueno; Ryuji & Habe; Tsuyoshi
    Assignee(s): SUCAMPO AG
    Disclosed is a novel composition comprising a novel bi-cyclic compound, which is expected to be pharmaceutically active, and a glyceride. The stability of the bi-cyclic compound can be improved significantly by dissolving the same in a glyceride.
    Patent expiration dates:

    • May 18, 2021
      ✓ 
      Drug substance




  • Composition and method for stabilizing the same
    Patent 8,097,649
    Issued: January 17, 2012
    Inventor(s): Ueno; Ryuji & Habe; Tsuyoshi
    Assignee(s): Sucampo AG
    Disclosed is a novel composition comprising a novel bi-cyclic compound, which is expected to be pharmaceutically active, and a glyceride. The stability of the bi-cyclic compound can be improved significantly by dissolving the same in a glyceride.
    Patent expiration dates:

    • October 16, 2020
      ✓ 
      Drug product




  • Dosage unit comprising a prostaglandin analog for treating constipation
    Patent 8,097,653
    Issued: January 17, 2012
    Inventor(s): Ueno; Ryuji & Patchen; Myra L.
    Assignee(s): Sucampo AG
    A dosage unit for treating constipation in a human patient is described. The dosage unit of the invention comprises a halogenated prostaglandin analog and a pharmaceutically suitable excipient. The dosage unit relieves constipation without substantial side effects.
    Patent expiration dates:

    • November 14, 2022
      ✓ 
      Patent use: METHOF FOR RELIEVING CONSTIPATION IN A HUMAN PATIENT THAT COMPRISES ADMINISTERING TO THE PATIENT A DOSAGE UNIT COMPRISING (I) 24MCG+/- 10% OF A DRUG SUBSTANCE AND (II) A PHARMACEUTICALLY SUITABLE EXCIPIENT




  • Anti-constipation composition
    Patent 8,114,890
    Issued: February 14, 2012
    Inventor(s): Ueno; Ryuji
    Assignee(s): Sucampo AG
    An object of the present invention is to provide an anti-constipation composition containing a halogenated-bi-cyclic compound as an active ingredient in ratio of bi-cyclic/mono-cyclic structure of at least 1:1. The halogenated-bi-cyclic compound is represented by Formula (I): where X1 and X2 are preferably both fluorine atoms. The composition can be used to treat constipation with out substantive side-effects, such as stomachache.
    Patent expiration dates:

    • September 5, 2020
      ✓ 
      Drug product



Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • January 31, 2011 - NEW CHEMICAL ENTITY

    • April 28, 2011 - NEW STRENGTH

    • April 28, 2011 - USE OF AMITIZA (LUBIPROSTONE) 8 MCG TWICE DAILY FOR TREATMENT OF IRRITABLE BOWEL SYNDROME WITH CONSTIPATION IN WOMEN GREATER THAN OR EQUAL TO 18 YEARS OLD

See also...

  • Amitiza Consumer Information (Drugs.com)
  • Amitiza Consumer Information (Wolters Kluwer)
  • Amitiza Consumer Information (Cerner Multum)
  • Amitiza Advanced Consumer Information (Micromedex)
  • Amitiza AHFS DI Monographs (ASHP)
  • Lubiprostone Consumer Information (Wolters Kluwer)
  • Lubiprostone Consumer Information (Cerner Multum)
  • Lubiprostone Advanced Consumer Information (Micromedex)
  • Lubiprostone AHFS DI Monographs (ASHP)

Nosca Mereprine




Nosca Mereprine may be available in the countries listed below.


Ingredient matches for Nosca Mereprine



Noscapine

Noscapine hydrochloride (a derivative of Noscapine) is reported as an ingredient of Nosca Mereprine in the following countries:


  • Belgium

  • Luxembourg

International Drug Name Search


Tuesday, October 25, 2016

Meningeal Leukemia Medications


Drugs associated with Meningeal Leukemia

The following drugs and medications are in some way related to, or used in the treatment of Meningeal Leukemia. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.





Drug List:


Simvastatin Streuli




Simvastatin Streuli may be available in the countries listed below.


Ingredient matches for Simvastatin Streuli



Simvastatin

Simvastatin is reported as an ingredient of Simvastatin Streuli in the following countries:


  • Switzerland

International Drug Name Search


Dopamine HCL DBL




Dopamine HCL DBL may be available in the countries listed below.


Ingredient matches for Dopamine HCL DBL



Dopamine

Dopamine hydrochloride (a derivative of Dopamine) is reported as an ingredient of Dopamine HCL DBL in the following countries:


  • Hong Kong

  • Indonesia

  • Singapore

International Drug Name Search


Glycoprotein platelet inhibitors


A drug may be classified by the chemical type of the active ingredient or by the way it is used to treat a particular condition. Each drug can be classified into one or more drug classes.

Glycoprotein platelet inhibitors prevent platelet adhesion by binding to the glycoprotein IIb/IIIa receptors on the plasma membrane of platelets. They stop the actual substrates of the glycoprotein receptors from binding to the receptor, so inhibit platelets from sticking together to form a thrombus, which can lead to stroke, myocardial infarction or deep vein thrombosis.


Glycoprotein platelet inhibitors are used in patients with angina, after a heart attack, angioplasty or other types of coronary vasculature procedures.

See also

Medical conditions associated with glycoprotein platelet inhibitors:

  • Acute Coronary Syndrome
  • Angina
  • Heart Attack
  • High Risk Percutaneous Transluminal Angioplasty
  • Percutaneous Coronary Intervention

Drug List:


Monday, October 24, 2016

Nandrolona Decanoato L. CH




Nandrolona Decanoato L.CH. may be available in the countries listed below.


Ingredient matches for Nandrolona Decanoato L.CH.



Nandrolone

Nandrolone 17ß-decanoate (a derivative of Nandrolone) is reported as an ingredient of Nandrolona Decanoato L.CH. in the following countries:


  • Chile

International Drug Name Search


Oxedep




Oxedep may be available in the countries listed below.


Ingredient matches for Oxedep



Fluoxetine

Fluoxetine hydrochloride (a derivative of Fluoxetine) is reported as an ingredient of Oxedep in the following countries:


  • Vietnam

International Drug Name Search


Nonivamide




Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0002444-46-4

Chemical Formula

C17-H27-NO3

Molecular Weight

231

Therapeutic Category

Topical agent: Hyperemic

Chemical Name

Nonanamide, N-[(4-hydroxy-3-methoxyphenyl)methyl]-

Foreign Names

  • Nonivamidum (Latin)
  • Nonivamid (German)
  • Nonivamide (French)
  • Nonivamida (Spanish)

Generic Names

  • Pseudocapsaicin (IS)
  • synthetisches Capsaicin (IS)

Brand Names

  • Finalgon (Nonivamide and Nicoboxil)
    Boehringer Ingelheim, Austria; Boehringer Ingelheim, Germany; Boehringer Ingelheim, New Zealand


  • Gothaplast
    Gothaplast, Germany


  • Nonivamide
    Beiersdorf, Greece

International Drug Name Search

Glossary

ISInofficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Doxam




Doxam may be available in the countries listed below.


Ingredient matches for Doxam



Doxycycline

Doxycycline monohydrate (a derivative of Doxycycline) is reported as an ingredient of Doxam in the following countries:


  • Germany

International Drug Name Search


Novabritine




Novabritine may be available in the countries listed below.


Ingredient matches for Novabritine



Amoxicillin

Amoxicillin sodium salt (a derivative of Amoxicillin) is reported as an ingredient of Novabritine in the following countries:


  • Luxembourg

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Novabritine in the following countries:


  • Luxembourg

International Drug Name Search


Sunday, October 23, 2016

Otic steroids


A drug may be classified by the chemical type of the active ingredient or by the way it is used to treat a particular condition. Each drug can be classified into one or more drug classes.

Otic steroids are products that contain corticosteroids and can be placed in the ears. Generally ophthalmic (eye) preparations containing corticosteroids are used in the ears. Corticosteroids are effective anti-inflammatory agents and are used to treat pain and inflammation, and eczema or dermatitis.

See also

Medical conditions associated with otic steroids:

  • Eczema

Drug List:


Zovast




Zovast may be available in the countries listed below.


Ingredient matches for Zovast



Simvastatin

Simvastatin is reported as an ingredient of Zovast in the following countries:


  • Philippines

International Drug Name Search


Quer-Out




Quer-Out may be available in the countries listed below.


Ingredient matches for Quer-Out



Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Quer-Out in the following countries:


  • Argentina

International Drug Name Search


Zenbron L




Zenbron L may be available in the countries listed below.


Ingredient matches for Zenbron L



Ambroxol

Ambroxol hydrochloride (a derivative of Ambroxol) is reported as an ingredient of Zenbron L in the following countries:


  • Japan

International Drug Name Search


Sensedol




Sensedol may be available in the countries listed below.


Ingredient matches for Sensedol



Capsaicin

Capsaicin is reported as an ingredient of Sensedol in the following countries:


  • Spain

International Drug Name Search


Narcan néonatal




Narcan néonatal may be available in the countries listed below.


Ingredient matches for Narcan néonatal



Naloxone

Naloxone hydrochloride (a derivative of Naloxone) is reported as an ingredient of Narcan néonatal in the following countries:


  • France

International Drug Name Search


Squint




Squint may be available in the countries listed below.


Ingredient matches for Squint



Benzylpenicillin

Benzylpenicillin potassium (a derivative of Benzylpenicillin) is reported as an ingredient of Squint in the following countries:


  • Myanmar

International Drug Name Search


HepaGel




HepaGel may be available in the countries listed below.


Ingredient matches for HepaGel



Heparin

Heparin sodium salt (a derivative of Heparin) is reported as an ingredient of HepaGel in the following countries:


  • Estonia

  • Latvia

  • Lithuania

  • Switzerland

International Drug Name Search


Niltro




Niltro may be available in the countries listed below.


Ingredient matches for Niltro



Loratadine

Loratadine is reported as an ingredient of Niltro in the following countries:


  • Argentina

International Drug Name Search


Zorkasept




Zorkasept may be available in the countries listed below.


Ingredient matches for Zorkasept



Benzalkonium Chloride

Benzalkonium chloride (a derivative of Benzalkonium) is reported as an ingredient of Zorkasept in the following countries:


  • Serbia

International Drug Name Search


Saturday, October 22, 2016

Quinapril HCT Helvepharm




Quinapril HCT Helvepharm may be available in the countries listed below.


Ingredient matches for Quinapril HCT Helvepharm



Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Quinapril HCT Helvepharm in the following countries:


  • Switzerland

Quinapril

Quinapril hydrochloride (a derivative of Quinapril) is reported as an ingredient of Quinapril HCT Helvepharm in the following countries:


  • Switzerland

International Drug Name Search


Quinestrol




In the US, Quinestrol is a member of the drug class estrogens.

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0000152-43-2

Chemical Formula

C25-H32-O2

Molecular Weight

364

Therapeutic Category

Estrogen

Chemical Name

19-Norpregna-1,3,5(10)-trien-20-yn-17-ol, 3-(cyclopentyloxy)-, (17α)-

Foreign Names

  • Quinestrolum (Latin)
  • Quinestrol (German)
  • Quinestrol (French)
  • Quinestrol (Spanish)

Generic Names

  • Quinestrol (OS: BAN, USAN, DCF)
  • Quinestrolo (OS: DCIT)
  • EECPE (IS)
  • W 3566 (IS)
  • Quinestrol (PH: USP XXII)

Brand Name

  • Qui-Lea
    Elea, Argentina

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Dobutamin Hexal




Dobutamin-Hexal may be available in the countries listed below.


Ingredient matches for Dobutamin-Hexal



Dobutamine

Dobutamine hydrochloride (a derivative of Dobutamine) is reported as an ingredient of Dobutamin-Hexal in the following countries:


  • Germany

  • Hungary

  • Luxembourg

  • Poland

  • Russian Federation

International Drug Name Search


Simvastatin-CT




Simvastatin-CT may be available in the countries listed below.


Ingredient matches for Simvastatin-CT



Simvastatin

Simvastatin is reported as an ingredient of Simvastatin-CT in the following countries:


  • Germany

International Drug Name Search


Neurogenic Bladder Medications


There are currently no drugs listed for "Neurogenic Bladder".

Definition of Neurogenic Bladder:

Neurogenic bladder is a urinary problem in which there is abnormal emptying of the bladder with subsequent retention or incontinence of urine. Depending on the type of nervous damage, the bladder may empty spontaneously (incontinence) or may not empty at all (retention with overflow leakage).


Some of the common causes for neurogenic bladder are nervous system tumor, trauma, or inflammatory conditions (such as multiple sclerosis).

Learn more about Neurogenic Bladder





Drug List:


Dextrometorfano Bromhidrato




Dextrometorfano Bromhidrato may be available in the countries listed below.


Ingredient matches for Dextrometorfano Bromhidrato



Dextromethorphan

Dextromethorphan is reported as an ingredient of Dextrometorfano Bromhidrato in the following countries:


  • Peru

International Drug Name Search


Friday, October 21, 2016

Omeprazol Rimafar




Omeprazol Rimafar may be available in the countries listed below.


Ingredient matches for Omeprazol Rimafar



Omeprazole

Omeprazole is reported as an ingredient of Omeprazol Rimafar in the following countries:


  • Spain

International Drug Name Search


Zosert




Zosert may be available in the countries listed below.


Ingredient matches for Zosert



Sertraline

Sertraline hydrochloride (a derivative of Sertraline) is reported as an ingredient of Zosert in the following countries:


  • Myanmar

International Drug Name Search


Optimycin




Optimycin may be available in the countries listed below.


Ingredient matches for Optimycin



Gentamicin

Gentamicin sulfate (a derivative of Gentamicin) is reported as an ingredient of Optimycin in the following countries:


  • Bangladesh

International Drug Name Search


Hyperthyroidism Medications


Definition of Hyperthyroidism: Hyperthyroidism is an imbalance of metabolism caused by overproduction of thyroid hormone.

Drugs associated with Hyperthyroidism

The following drugs and medications are in some way related to, or used in the treatment of Hyperthyroidism. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Learn more about Hyperthyroidism





Drug List:


Stavudine




In the US, Stavudine (stavudine systemic) is a member of the drug class nucleoside reverse transcriptase inhibitors (NRTIs) and is used to treat HIV Infection and Nonoccupational Exposure.

US matches:

  • Stavudine

  • Stavudine Solution

  • Stavudine Oral Solution

Scheme

Prop.INN

ATC (Anatomical Therapeutic Chemical Classification)

J05AF04

CAS registry number (Chemical Abstracts Service)

0003056-17-5

Chemical Formula

C10-H12-N2-O4

Molecular Weight

224

Therapeutic Category

Antiviral agent, HIV reverse transcriptase inhibitor

Chemical Name

1-(2,3-Dideoxy-ß-D-glycero-pent-2-enofuranosyl)thymine

Foreign Names

  • Stavudinum (Latin)
  • Stavudin (German)
  • Stavudine (French)
  • Estavudina (Spanish)

Generic Names

  • Sanilvudine (OS: JAN)
  • Stavudine (OS: BAN, USAN)
  • BMY 27857 (IS: Bristol-Myers)
  • d4T (IS)
  • Stavudine (PH: BP 2010, Ph. Int. 4, USP 32, Ph. Eur. 6)
  • Stavudinum (PH: Ph. Eur. 6)

Brand Names

  • Actastav
    Actavis, Russian Federation


  • Aspen Stavudine
    Aspen Pharmacare, South Africa


  • Avostav
    Ranbaxy Laboratories, Ethiopia


  • Ciplastavir
    Biotoscana, Colombia


  • Coviro (Stavudine and Lamivudine)
    Ranbaxy, Myanmar


  • Emduo (Stavudine and Lamivudine)
    Emcure, Myanmar


  • Emtri (Stavudine and Lamivudine, + Nevirapine)
    Emcure, Myanmar


  • Estavudina
    Induquimica, Peru


  • Estavudox
    Biotoscana, Peru


  • Exvihr
    Biogen, Colombia; Biogen, Peru


  • Flamistav
    Flamingo Pharmacueticals, Ethiopia


  • Lamitec-S (Stavudine and Lamivudine)
    Zifam India, Myanmar


  • Landstav
    Landsteiner, Mexico


  • Lazid (Stavudine and Lamivudine)
    Emcure, Myanmar


  • Lion
    Filaxis, Argentina


  • Maxivir (Stavudine and Lamivudine, + Nevirapine)
    Okasa, Myanmar


  • Medilam (Stavudine and Lamivudine)
    Meditab, Myanmar


  • S.T.V.
    Ivax, Argentina


  • Sonke-LamiNevStav (Stavudine and Lamivudine, + Nevirapine)
    Ranbaxy, South Africa


  • Sonke-Stavudine
    Ranbaxy, South Africa


  • Stadine
    Emcure, Myanmar


  • Stamar
    LKM, Argentina


  • Stavex
    Aurobindo Pharma, Ethiopia


  • Stavir
    Cipla, Ethiopia; Cipla, Georgia; Cipla, India; Cipla Medpro, South Africa; Pharmaceutical, Venezuela


  • Stavubergen
    Paylos, Argentina


  • Stavudina Dosa
    Dosa, Argentina


  • Stavudine Stada
    Stada, Vietnam


  • Stavudine
    Aurobindo, United States; Cipla, United States; Hetero, United States; Mylan, United States


  • Tonavir
    Richmond, Argentina; Richmond, Peru


  • Triomune (Stavudine and Lamivudine, + Nevirapine)
    Cipla Medpro, South Africa


  • Virolans (Stavudine and Lamivudine, + Nevirapine)
    Ranbaxy, Myanmar


  • Virozen (Stavudine and Lamivudine, + Nevirapine)
    Zifam India, Myanmar


  • Zerit
    Bristol-Myers Squibb, Argentina; Bristol-Myers Squibb, Austria; Bristol-Myers Squibb, Australia; Bristol-Myers Squibb, Bosnia & Herzegowina; Bristol-Myers Squibb, Belgium; Bristol-Myers Squibb, Burkina Faso; Bristol-Myers Squibb, Burundi; Bristol-Myers Squibb, Benin; Bristol-Myers Squibb, Canada; Bristol-Myers Squibb, Congo; Bristol-Myers Squibb, Switzerland; Bristol-Myers Squibb, Cote D'ivoire; Bristol-Myers Squibb, Chile; Bristol-Myers Squibb, Cameroon; Bristol-Myers Squibb, Colombia; Bristol-Myers Squibb, Czech Republic; Bristol-Myers Squibb, Germany; Bristol-Myers Squibb, Denmark; Bristol-Myers Squibb, Algeria; Bristol-Myers Squibb, Spain; Bristol-Myers Squibb, Ethiopia; Bristol-Myers Squibb, Finland; Bristol-Myers Squibb, France; Bristol-Myers Squibb, Gabon; Bristol-Myers Squibb, United Kingdom; Bristol-Myers Squibb, Georgia; Bristol-Myers Squibb, Guinea; Bristol-Myers Squibb, Greece; Bristol-Myers Squibb, Hong Kong; Bristol-Myers Squibb, Hungary; Bristol-Myers Squibb, Ireland; Bristol-Myers Squibb, Iceland; Bristol-Myers Squibb, Italy; Bristol-Myers Squibb, Japan; Bristol-Myers Squibb, Luxembourg; Bristol-Myers Squibb, Mali; Bristol-Myers Squibb, Mauritania; Bristol-Myers Squibb, Mexico; Bristol-Myers Squibb, Niger; Bristol-Myers Squibb, Netherlands; Bristol-Myers Squibb, Norway; Bristol-Myers Squibb, New Zealand; Bristol-Myers Squibb, Peru; Bristol-Myers Squibb, Poland; Bristol-Myers Squibb, Portugal; Bristol-Myers Squibb, Romania; Bristol-Myers Squibb, Serbia; Bristol-Myers Squibb, Russian Federation; Bristol-Myers Squibb, Sweden; Bristol-Myers Squibb, Singapore; Bristol-Myers Squibb, Slovenia; Bristol-Myers Squibb, Senegal; Bristol-Myers Squibb, Chad; Bristol-Myers Squibb, Togo; Bristol-Myers Squibb, Thailand; Bristol-Myers Squibb, Tunisia; Bristol-Myers Squibb, Turkey; Bristol-Myers Squibb, Taiwan; Bristol-Myers Squibb, United States; Bristol-Myers Squibb, Venezuela; Bristol-Myers Squibb, South Africa; Bristol-Myers Squibb, Zaire; PharmaSwiss, Croatia (Hrvatska)

International Drug Name Search

Glossary

BANBritish Approved Name
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Prop.INNProposed International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday, October 20, 2016

Urzac




Urzac may be available in the countries listed below.


Ingredient matches for Urzac



Ursodeoxycholic Acid

Ursodeoxycholic Acid is reported as an ingredient of Urzac in the following countries:


  • Argentina

International Drug Name Search


Secnid




Secnid may be available in the countries listed below.


Ingredient matches for Secnid



Secnidazole

Secnidazole is reported as an ingredient of Secnid in the following countries:


  • Bangladesh

International Drug Name Search


Varnoline




Varnoline may be available in the countries listed below.


Ingredient matches for Varnoline



Desogestrel

Desogestrel is reported as an ingredient of Varnoline in the following countries:


  • France

Ethinylestradiol

Ethinylestradiol is reported as an ingredient of Varnoline in the following countries:


  • France

International Drug Name Search


Diabiformin




Diabiformin may be available in the countries listed below.


Ingredient matches for Diabiformin



Chlorpropamide

Chlorpropamide is reported as an ingredient of Diabiformin in the following countries:


  • Switzerland

Metformin

Metformin hydrochloride (a derivative of Metformin) is reported as an ingredient of Diabiformin in the following countries:


  • Switzerland

International Drug Name Search


Spiramycine Métronidazole Winthrop




Spiramycine Métronidazole Winthrop may be available in the countries listed below.


Ingredient matches for Spiramycine Métronidazole Winthrop



Metronidazole

Metronidazole is reported as an ingredient of Spiramycine Métronidazole Winthrop in the following countries:


  • France

Spiramycin

Spiramycin is reported as an ingredient of Spiramycine Métronidazole Winthrop in the following countries:


  • France

International Drug Name Search


Omeprazol Normon




Omeprazol Normon may be available in the countries listed below.


Ingredient matches for Omeprazol Normon



Omeprazole

Omeprazole is reported as an ingredient of Omeprazol Normon in the following countries:


  • Costa Rica

  • Dominican Republic

  • El Salvador

  • Guatemala

  • Honduras

  • Nicaragua

  • Panama

  • Spain

International Drug Name Search


Napageln




Napageln may be available in the countries listed below.


Ingredient matches for Napageln



Felbinac

Felbinac is reported as an ingredient of Napageln in the following countries:


  • Japan

International Drug Name Search


Vitaxicam




Vitaxicam may be available in the countries listed below.


Ingredient matches for Vitaxicam



Piroxicam

Piroxicam is reported as an ingredient of Vitaxicam in the following countries:


  • Dominican Republic

  • Panama

  • Singapore

  • Spain

International Drug Name Search


Wednesday, October 19, 2016

Spironolacton CF




Spironolacton CF may be available in the countries listed below.


Ingredient matches for Spironolacton CF



Spironolactone

Spironolactone is reported as an ingredient of Spironolacton CF in the following countries:


  • Netherlands

International Drug Name Search


Sebtet




Sebtet may be available in the countries listed below.


Ingredient matches for Sebtet



Felbinac

Felbinac is reported as an ingredient of Sebtet in the following countries:


  • Japan

International Drug Name Search


Evoclin


Evoclin is a brand name of clindamycin topical, approved by the FDA in the following formulation(s):


EVOCLIN (clindamycin phosphate - aerosol, foam; topical)



  • Manufacturer: STIEFEL LABS INC

    Approval date: October 22, 2004

    Strength(s): 1% [RLD][AT]

Has a generic version of Evoclin been approved?


A generic version of Evoclin has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Evoclin and have been approved by the FDA:


clindamycin phosphate aerosol, foam; topical



  • Manufacturer: PERRIGO UK FINCO

    Approval date: March 31, 2010

    Strength(s): 1% [AT]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Evoclin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Pharmaceutical foam
    Patent 7,141,237
    Issued: November 28, 2006
    Inventor(s): Abram; Albert Zorko & Hunt; Barry Thomas
    Assignee(s): Connetics Australia Pty Ltd.
    The present invention provides various pharmaceutically active topical delivery compositions. In particular, compositions of the present invention are present in a pressurized container comprising a quick-breaking alcoholic foaming agent, such that when the composition is released, i.e., dispensed, from the pressurized container, a quick-breaking temperature sensitive foam is formed. In addition, the present invention provides various aspects related to such compositions, including methods for modulating a foam characteristic, methods for improving the shelf-life of a pharmaceutically active compound, methods for the percutaneous treatment of various diseases, infections, and illnesses, and methods for evaluating foam characteristics.
    Patent expiration dates:

    • January 23, 2024
      ✓ 
      Drug substance
      ✓ 
      Drug product




  • Pharmaceutical foam
    Patent 7,374,747
    Issued: May 20, 2008
    Inventor(s): Abram; Albert Zorko & Hunt; Barry Thomas
    Assignee(s): Stiefel Research Australia, Pty Ltd.
    The present invention provides various pharmaceutically active topical delivery compositions. In particular, compositions of the present invention are present in a pressurized contained comprising a quick-breaking alcoholic foaming agent, such that when the composition is released, i.e., dispensed, from the pressurized container, a quick-breaking temperature sensitive foam is formed. In addition, the present invention provides various aspects related to such compositions, including methods for modulating a foam characteristic, methods for improving the shelf-life of a pharmaceutically active compound, methods for the percutaneous treatment of various diseases, infections, and illnesses, and methods for evaluating foam characteristics.
    Patent expiration dates:

    • August 9, 2026
      ✓ 
      Patent use: TREATMENT OF ACNE VULGARIS
      ✓ 
      Drug substance
      ✓ 
      Drug product



See also...

  • Evoclin Consumer Information (Drugs.com)
  • Evoclin Foam Consumer Information (Wolters Kluwer)
  • Evoclin Consumer Information (Cerner Multum)
  • Evoclin Topical Advanced Consumer Information (Micromedex)
  • Clindamycin Cream Consumer Information (Wolters Kluwer)
  • Clindamycin Foam Consumer Information (Wolters Kluwer)
  • Clindamycin Gel Consumer Information (Wolters Kluwer)
  • Clindamycin Lotion Consumer Information (Wolters Kluwer)
  • Clindamycin Solution Consumer Information (Wolters Kluwer)
  • Clindamycin Suppositories Consumer Information (Wolters Kluwer)
  • Clindamycin Swab Consumer Information (Wolters Kluwer)
  • Clindamycin topical Consumer Information (Cerner Multum)
  • Clindamycin vaginal Consumer Information (Cerner Multum)
  • Z-Clinz Topical Advanced Consumer Information (Micromedex)
  • Clindamycin Topical Advanced Consumer Information (Micromedex)
  • Clindamycin Vaginal Advanced Consumer Information (Micromedex)
  • Clindamycin Phosphate topical AHFS DI Monographs (ASHP)

Somatron




Somatron may be available in the countries listed below.


Ingredient matches for Somatron



Cefteram

Cefteram pivoxil (a derivative of Cefteram) is reported as an ingredient of Somatron in the following countries:


  • Japan

International Drug Name Search


Zophren




Zophren may be available in the countries listed below.


Ingredient matches for Zophren



Ondansetron

Ondansetron is reported as an ingredient of Zophren in the following countries:


  • France

  • Tunisia

Ondansetron hydrochloride (a derivative of Ondansetron) is reported as an ingredient of Zophren in the following countries:


  • France

International Drug Name Search


Dolofin




Dolofin may be available in the countries listed below.


Ingredient matches for Dolofin



Ibuprofen

Ibuprofen is reported as an ingredient of Dolofin in the following countries:


  • Belgium

  • Luxembourg

International Drug Name Search


Tuesday, October 18, 2016

Sendoxan




Sendoxan may be available in the countries listed below.


Ingredient matches for Sendoxan



Cyclophosphamide

Cyclophosphamide is reported as an ingredient of Sendoxan in the following countries:


  • Denmark

  • Iceland

Cyclophosphamide monohydrate (a derivative of Cyclophosphamide) is reported as an ingredient of Sendoxan in the following countries:


  • Finland

  • Norway

  • Sweden

International Drug Name Search


Zcure




Zcure may be available in the countries listed below.


Ingredient matches for Zcure



Pyrazinamide

Pyrazinamide is reported as an ingredient of Zcure in the following countries:


  • Philippines

International Drug Name Search


Neblik




Neblik may be available in the countries listed below.


Ingredient matches for Neblik



Formoterol

Formoterol fumarate (a derivative of Formoterol) is reported as an ingredient of Neblik in the following countries:


  • Spain

International Drug Name Search


Sorbifer




Sorbifer may be available in the countries listed below.


Ingredient matches for Sorbifer



Ascorbic Acid

Ascorbic Acid is reported as an ingredient of Sorbifer in the following countries:


  • Hungary

  • Poland

  • Slovakia

Ferrous Sulfate

Ferrous Sulfate is reported as an ingredient of Sorbifer in the following countries:


  • Bulgaria

  • Czech Republic

  • Georgia

  • Hungary

  • Philippines

  • Poland

  • Slovakia

International Drug Name Search


Viracept




In the US, Viracept (nelfinavir systemic) is a member of the drug class protease inhibitors and is used to treat HIV Infection, Nonoccupational Exposure and Occupational Exposure.

US matches:

  • Viracept

  • Viracept Powder

UK matches:

  • Viracept Film-coated Tablets (Roche Products Limited) (SPC)

Ingredient matches for Viracept



Nelfinavir

Nelfinavir is reported as an ingredient of Viracept in the following countries:


  • Ireland

Nelfinavir mesilate (a derivative of Nelfinavir) is reported as an ingredient of Viracept in the following countries:


  • Argentina

  • Belgium

  • Bosnia & Herzegowina

  • Botswana

  • Brazil

  • Cambodia

  • Canada

  • Chile

  • Colombia

  • Croatia (Hrvatska)

  • Czech Republic

  • Ecuador

  • Egypt

  • Estonia

  • Ethiopia

  • Finland

  • France

  • Georgia

  • Germany

  • Ghana

  • Greece

  • Hong Kong

  • Hungary

  • Iceland

  • Israel

  • Italy

  • Japan

  • Kazakhstan

  • Kenya

  • Laos

  • Luxembourg

  • Malawi

  • Malaysia

  • Mexico

  • Morocco

  • Namibia

  • Netherlands

  • Nigeria

  • Oman

  • Paraguay

  • Peru

  • Philippines

  • Poland

  • Portugal

  • Qatar

  • Romania

  • Russian Federation

  • Serbia

  • Singapore

  • Slovakia

  • Slovenia

  • Spain

  • Sudan

  • Switzerland

  • Taiwan

  • Tanzania

  • Thailand

  • Uganda

  • United Arab Emirates

  • United Kingdom

  • United States

  • Uruguay

  • Venezuela

  • Zambia

  • Zimbabwe

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Ophthazinc T




Ophthazinc T may be available in the countries listed below.


Ingredient matches for Ophthazinc T



Zinc Sulfate

Zinc Sulfate monohydrate (a derivative of Zinc Sulfate) is reported as an ingredient of Ophthazinc T in the following countries:


  • Japan

International Drug Name Search


Sumatriptan-Hormosan




Sumatriptan-Hormosan may be available in the countries listed below.


Ingredient matches for Sumatriptan-Hormosan



Sumatriptan

Sumatriptan succinate (a derivative of Sumatriptan) is reported as an ingredient of Sumatriptan-Hormosan in the following countries:


  • Germany

International Drug Name Search


Sigondan




Sigondan may be available in the countries listed below.


Ingredient matches for Sigondan



Ondansetron

Ondansetron hydrochloride dihydrate (a derivative of Ondansetron) is reported as an ingredient of Sigondan in the following countries:


  • Germany

International Drug Name Search


Intestinal Arterial Insufficiency Medications


Drugs associated with Intestinal Arterial Insufficiency

The following drugs and medications are in some way related to, or used in the treatment of Intestinal Arterial Insufficiency. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.





Drug List:


Monday, October 17, 2016

Oxybutynin Hexal




Oxybutynin Hexal may be available in the countries listed below.


Ingredient matches for Oxybutynin Hexal



Oxybutynin

Oxybutynin hydrochloride (a derivative of Oxybutynin) is reported as an ingredient of Oxybutynin Hexal in the following countries:


  • Austria

  • Germany

International Drug Name Search


Nosocomial Pneumonia Medications


Definition of Nosocomial Pneumonia: An infection of the lungs contracted during a hospital stay.

Drugs associated with Nosocomial Pneumonia

The following drugs and medications are in some way related to, or used in the treatment of Nosocomial Pneumonia. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.





Drug List:


Neoset




Neoset may be available in the countries listed below.


Ingredient matches for Neoset



Sulfamethoxazole

Sulfamethoxazole is reported as an ingredient of Neoset in the following countries:


  • Bangladesh

Trimethoprim

Trimethoprim is reported as an ingredient of Neoset in the following countries:


  • Bangladesh

International Drug Name Search


Delphicort




Delphicort may be available in the countries listed below.


Ingredient matches for Delphicort



Triamcinolone

Triamcinolone is reported as an ingredient of Delphicort in the following countries:


  • Germany

Triamcinolone 16α,21-diacetate (a derivative of Triamcinolone) is reported as an ingredient of Delphicort in the following countries:


  • Germany

International Drug Name Search


Dihydergot Nosni Sprey




Dihydergot Nosni Sprey may be available in the countries listed below.


Ingredient matches for Dihydergot Nosni Sprey



Dihydroergotamine

Dihydroergotamine mesilate (a derivative of Dihydroergotamine) is reported as an ingredient of Dihydergot Nosni Sprey in the following countries:


  • Czech Republic

International Drug Name Search


Hytacand Orifarm




Hytacand Orifarm may be available in the countries listed below.


Ingredient matches for Hytacand Orifarm



Candesartan

Candesartan cilexetil (a derivative of Candesartan) is reported as an ingredient of Hytacand Orifarm in the following countries:


  • Denmark

Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Hytacand Orifarm in the following countries:


  • Denmark

International Drug Name Search


Ozagrel Hydrochloride




Ozagrel Hydrochloride may be available in the countries listed below.


Ingredient matches for Ozagrel Hydrochloride



Ozagrel

Ozagrel Hydrochloride (JAN) is also known as Ozagrel (Rec.INN)

International Drug Name Search

Glossary

JANJapanese Accepted Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

DTIC-Dome




In some countries, this medicine may only be approved for veterinary use.


In the US, DTIC-Dome (dacarbazine systemic) is a member of the drug class alkylating agents and is used to treat Hodgkin's Lymphoma and Melanoma.

US matches:

  • DTIC-Dome

Ingredient matches for DTIC-Dome



Dacarbazine

Dacarbazine citrate (a derivative of Dacarbazine) is reported as an ingredient of DTIC-Dome in the following countries:


  • United Kingdom

International Drug Name Search


Ome TAD




Ome TAD may be available in the countries listed below.


Ingredient matches for Ome TAD



Omeprazole

Omeprazole is reported as an ingredient of Ome TAD in the following countries:


  • Germany

International Drug Name Search


Hydergine


Hydergine is a brand name of ergoloid mesylates, approved by the FDA in the following formulation(s):


HYDERGINE (ergoloid mesylates - tablet; oral)



  • Manufacturer: NOVARTIS

    Approved Prior to Jan 1, 1982

    Strength(s): 1MG [RLD][AB]

Has a generic version of Hydergine been approved?


Yes. The following products are equivalent to Hydergine:


ergoloid mesylates tablet; oral



  • Manufacturer: MUTUAL PHARM

    Approval date: October 31, 1991

    Strength(s): 1MG [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Hydergine. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Hydergine.

See also...

  • Hydergine Consumer Information (Wolters Kluwer)
  • Hydergine Consumer Information (Cerner Multum)
  • Hydergine Advanced Consumer Information (Micromedex)
  • Ergoloid Mesylates Consumer Information (Wolters Kluwer)
  • Ergoloid mesylates Consumer Information (Cerner Multum)
  • Ergoloid mesylates Oral, Sublingual Advanced Consumer Information (Micromedex)